NASDAQ:TNDM
Tandem Diabetes Care Stock News
$35.24
-0.320 (-0.90%)
At Close: Apr 26, 2024
Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022
04:05pm, Tuesday, 12'th Jul 2022
SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2022 results after the
Tandem Diabetes Care: Strong Financials And Revenue, Overpenalized For Missed Earnings
10:50am, Friday, 08'th Jul 2022
TNDM revenue continues to grow as the company increases market share in an expanding industry. Mixed Q4 2021 and Q1 2022 earnings, coupled with the overall market downturn, have created an extremely l
Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes
01:13pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes
10:54am, Wednesday, 06'th Jul 2022
Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.
CVRx (CVRX) Soars 5.6%: Is Further Upside Left in the Stock?
01:23pm, Monday, 27'th Jun 2022 Zacks Investment Research
CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Tandem Diabetes (TNDM) Global Pump Sales Aid, Price Issue Ails
01:31pm, Friday, 24'th Jun 2022 Zacks Investment Research
Tandem Diabetes (TNDM) is witnessing strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Tandem Diabetes (TNDM) Global Pump Sales Aid, Price Issue Ails
10:55am, Friday, 24'th Jun 2022
Tandem Diabetes (TNDM) is witnessing strong customer retention, driven by the impressive positive response from the Control-IQ technology.
Here's Why Investors Should Retain Tandem Diabetes (TNDM) Now
04:10pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
Investors are optimistic about Tandem Diabetes' (TNDM) strong pump shipments and ongoing product innovations.
Here's Why Investors Should Retain Tandem Diabetes (TNDM) Now
01:55pm, Wednesday, 22'nd Jun 2022
Investors are optimistic about Tandem Diabetes' (TNDM) strong pump shipments and ongoing product innovations.
Tandem Diabetes Care, Inc. (TNDM) Soars 6%: Is Further Upside Left in the Stock?
12:53pm, Monday, 20'th Jun 2022 Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further st
Tandem Diabetes Care, Inc. (TNDM) Soars 6%: Is Further Upside Left in the Stock?
10:06am, Monday, 20'th Jun 2022
Tandem Diabetes Care, Inc. (TNDM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further st
3 Humbled Nasdaq Stocks Ready to Bounce Back
12:19pm, Tuesday, 14'th Jun 2022 The Motley Fool
These names are at the bottom of the bargain bin.
2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street
03:30pm, Wednesday, 08'th Jun 2022 The Motley Fool
These diabetes specialists are down but not out.
2 Beaten-Down Stocks With 80% to 113% Upside, According to Wall Street
11:30am, Wednesday, 08'th Jun 2022
These diabetes specialists are down but not out.
Tandem Diabetes (TNDM) Posts Positive Control-IQ Study Data
02:10pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Data presented at the ADA conference demonstrates Tandem Diabetes' (TNDM) Control-IQ technology's ability to make a positive and sustained impact across a diverse group of people with diabetes.
